Results 81 to 90 of about 2,146 (159)

Complement inhibitor therapy in atypical hemolytic uremic syndrome (aHUS): evaluating the economic impact of introducing eculizumab biosimilars in Germany. [PDF]

BMC Nephrol
Kaufhold I, Lewkowicz D, Seidel D, Brinkkoetter PT, Kron F.   +4 more
europepmc   +1 more source

A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab. [PDF]

Clin Kidney J
Gopireddy NSR, Kumar A, Smith RJH, Nester CM, Thomas CP.   +4 more
europepmc   +1 more source

Ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria during pregnancy. [PDF]

Blood Adv
Höchsmann B, Gerber GF, Leopold W, Patel BJ, Gavriilaki E, Hefter A, Kalhammer U, Opitz S, Marx-Hoffmann A, Knight DB, Brodsky RA, Marvaki A, Lalayanni C, Körper S, Babushok DV, Schrezenmeier H.   +15 more
europepmc   +1 more source

Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk. [PDF]

Front Immunol
Vahldieck C, Fels B.
europepmc   +1 more source

Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring. [PDF]

Ann Clin Transl Neurol
Saccà F, Pelto R.
europepmc   +1 more source

FcRn antagonist and C5 complement inhibitor as early rescue strategies in severe Myasthenia Gravis: a two-case report. [PDF]

Front Immunol
Parisi M, Molitierno N, Alberti C, Gagliardi D, Velardo D, Comi GP, Corti SP.   +6 more
europepmc   +1 more source

Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab". [PDF]

Ann Clin Transl Neurol
Gerischer L, Schroeder-Braunstein J, Wabnitz G, Meisel A.   +3 more
europepmc   +1 more source

Beyond Terminal Blockade: A Mechanism-Based Approach to Complement Inhibitor Selection in Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Drug Des Devel Ther
Chen C, Zhong J, Xiong D.
europepmc   +1 more source

Multidomain Fatigue, Cognitive, and Quality of Life Observations in Generalized Myasthenia Gravis Under Ravulizumab: A Case Series. [PDF]

Neurol Ther
Zanghì A, Di Filippo PS, Rutigliano C, Avolio C, D'Amico E.   +4 more
europepmc   +1 more source

Time-Related Burden of Treatment With Parenterally Administered Complement Inhibitors: A Mixed Methods Observational Study Exploring Experiences among Patients With Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Health Sci Rep
Dingli D, Broderick L, Rizio AA, Rucker S, LaGasse K, Carty MK, Burton E, Gordon S, Yen GP, Paulose J, Geevarghese A, Lee S.   +11 more
europepmc   +1 more source